Clinical Trial Update: Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating relative exposure and safety of Kimyrsa in acute bacterial skin and skin structure infection (ABSSSI) patients; study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infection

Drugs mentioned

• KIMYRSA (oritavancin diphosphate)

Snippet

Sponsor: Melinta Therapeutics, Inc. | Conditions: Acute Bacterial Skin and Skin Structure Infection | Phase 1 | Status: COMPLETED | Results posted: 2021-04-13